首页>
外国专利>
Combination therapy using an anti-EGFR agent(s) and IGF-1R specific inhibitors
Combination therapy using an anti-EGFR agent(s) and IGF-1R specific inhibitors
展开▼
机译:使用抗EGFR药物和IGF-1R特异性抑制剂的联合治疗
展开▼
页面导航
摘要
著录项
相似文献
摘要
The combination of an IGF-1R antagonist such as a humanized antibody and an anti-proliferative drug is described. In a preferred embodiment, the present invention describes the combination of an IGF-1R antibody and an anti-proliferative drug belonging to the EGFR-inhibitor class, which is preferably erlotinib. The combination according to the present invention is useful for the treatment of tumours, including IGF-1R and /or EGFR mediated or dependent tumours.
展开▼